UBS Group’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,709
| Closed | -$2.79K | – | 10276 |
|
|
2023
Q2 | $2.79K | Buy |
1,709
+1,645
| +2,570% | +$3.05K | ﹤0.01% | 7694 |
|
|
2023
Q1 | $147 | Sell |
64
-3,887
| -98% | -$20.3K | ﹤0.01% | 9179 |
|
|
2022
Q4 | $23.5K | Buy |
3,951
+2,635
| +200% | +$15.8K | ﹤0.01% | 7483 |
|
|
2022
Q3 | $8K | Buy |
1,316
+542
| +70% | +$4.09K | ﹤0.01% | 8795 |
|
|
2022
Q2 | $6K | Buy |
774
+175
| +29% | +$1.49K | ﹤0.01% | 8780 |
|
|
2022
Q1 | $5K | Sell |
599
-391
| -39% | -$3.54K | ﹤0.01% | 9211 |
|
|
2021
Q4 | $9K | Buy |
990
+589
| +147% | +$7.89K | ﹤0.01% | 8968 |
|
|
2021
Q3 | $7K | Buy |
401
+319
| +389% | +$5.75K | ﹤0.01% | 8362 |
|
|
2021
Q2 | $2K | Sell |
82
-116
| -59% | -$2.33K | ﹤0.01% | 9027 |
|
|
2021
Q1 | $4K | Sell |
198
-153
| -44% | -$11.5K | ﹤0.01% | 8452 |
|
|
2020
Q4 | $22K | Sell |
351
-30
| -8% | -$1.72K | ﹤0.01% | 6887 |
|
|
2020
Q3 | $14K | Sell |
381
-121
| -24% | -$4.3K | ﹤0.01% | 6605 |
|
|
2020
Q2 | $15K | Buy |
502
+84
| +20% | +$2.59K | ﹤0.01% | 6758 |
|
|
2020
Q1 | $9K | Buy |
418
+149
| +55% | +$4.04K | ﹤0.01% | 7031 |
|
|
2019
Q4 | $8K | Sell |
269
-139
| -34% | -$5.17K | ﹤0.01% | 7410 |
|
|
2019
Q3 | $20K | Sell |
408
-14
| -3% | -$615 | ﹤0.01% | 6744 |
|
|
2019
Q2 | $19K | Buy |
422
+259
| +159% | +$12.3K | ﹤0.01% | 6662 |
|
|
2019
Q1 | $7K | Sell |
163
-729
| -82% | -$35.3K | ﹤0.01% | 7032 |
|
|
2018
Q4 | $42K | Buy |
892
+379
| +74% | +$43.6K | ﹤0.01% | 6255 |
|
|
2018
Q3 | $78K | Sell |
513
-481
| -48% | -$68.7K | ﹤0.01% | 5793 |
|
|
2018
Q2 | $179K | Buy |
994
+860
| +642% | +$201K | ﹤0.01% | 5034 |
|
|
2018
Q1 | $34K | Sell |
134
-201
| -60% | -$55.1K | ﹤0.01% | 6003 |
|
|
2017
Q4 | $96K | Buy |
335
+3
| +0.9% | +$857 | ﹤0.01% | 5383 |
|
|
2017
Q3 | $100K | Buy |
332
+135
| +69% | +$35.3K | ﹤0.01% | 5321 |
|
|
2017
Q2 | $46K | Sell |
197
-130
| -40% | -$34K | ﹤0.01% | 5719 |
|
|
2017
Q1 | $110K | Sell |
327
-219
| -40% | -$52.8K | ﹤0.01% | 5019 |
|
|
2016
Q4 | $112K | Buy |
546
+379
| +227% | +$90.4K | ﹤0.01% | 5214 |
|
|
2016
Q3 | $58K | Buy |
167
+4
| +2% | +$1.06K | ﹤0.01% | 5394 |
|
|
2016
Q2 | $34K | Hold |
163
| – | – | ﹤0.01% | 5847 |
|
|
2016
Q1 | $44K | Buy |
163
+14
| +9% | +$3.74K | ﹤0.01% | 5600 |
|
|
2015
Q4 | $62K | Sell |
149
-119
| -44% | -$53.2K | ﹤0.01% | 5635 |
|
|
2015
Q3 | $122K | Buy |
268
+128
| +91% | +$56.6K | ﹤0.01% | 5056 |
|
|
2015
Q2 | $70K | Buy |
140
+90
| +180% | +$41.3K | ﹤0.01% | 5702 |
|
|
2015
Q1 | $25K | Sell |
50
-45
| -47% | -$27.4K | ﹤0.01% | 6752 |
|
|
2014
Q4 | $56K | Buy |
+95
| New | +$38.1K | ﹤0.01% | 6360 |
|
Other funds holding ACGN
UBS Group's ACGN Position: Q3 2023 in Review
UBS Group sold out of Aceragen Inc (ACGN) in Q3 2023, closing a stake of 1,709 shares — an estimated $2.79K sold.
UBS Group first reported a position in ACGN in Q4 2014 and held it in 35 quarters. The position peaked at $179K in Q2 2018. 3 funds tracked by Wall St. Rank hold ACGN as of Q3 2023.
- UBS Group reported no remaining Aceragen Inc position as of Q3 2023 after selling out during the quarter.
- UBS Group sold 1,709 Aceragen Inc shares in Q3 2023, an estimated $2.79K.
- UBS Group first reported a position in Aceragen Inc in Q4 2014 and held it in 35 quarters.
- UBS Group's Aceragen Inc position peaked at $179K in Q2 2018.
- 3 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2023.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.